MedTrace Logo

Vagus Nerve Stimulation for Management of Bronchoconstriction in Patients Hospitalized With COPD Exacerbations

NCT01612793 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2019-02-28

Study results available
· View outcomes & findings →

Summary

This study will look at the safety, improving symptoms and decreasing the length of stay of patients admitted to the hospital with COPD.

Conditions

Interventions

DEVICE

AlphaCore Device

multiple stimulation treatments per day for duration of hospitalization

Sponsors & Collaborators

  • ElectroCore INC

    lead INDUSTRY

Principal Investigators

  • Brian Rowe, M.D. · University of Alberta

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612793 on ClinicalTrials.gov